Clinical Characteristics and Treatment Allocations in Patients with Myelodysplastic Syndromes and Monosomy 7: Results from an International Multicenter Study Suggest That Hypomethylating Agents Significantly Improve Overall-and AML-Free Survival in Patients Classified As Very High Risk By IPSS-R

Schanz, JulieJulieSchanzBraulke, FriederikeFriederikeBraulkeMufti, Ghulam J.Ghulam J.MuftiCrisa, ElenaElenaCrisaKulasekararaj, AustinAustinKulasekararajNachtkamp, KathrinKathrinNachtkampGerming, UlrichUlrichGermingSchmitz, Stephan A.Stephan A.SchmitzHaas, PeterPeterHaasLuebbert, MichaelMichaelLuebbertMueller-Thomas, CatharinaCatharinaMueller-ThomasGoetze, Katharina S.Katharina S.GoetzePlatzbecker, UweUwePlatzbeckerNolte, FlorianFlorianNolteHofmann, Wolf-KarstenWolf-KarstenHofmannHaase, DetlefDetlefHaase2018-11-072018-11-072014https://resolver.sub.uni-goettingen.de/purl?gro-2/31537Clinical Characteristics and Treatment Allocations in Patients with Myelodysplastic Syndromes and Monosomy 7: Results from an International Multicenter Study Suggest That Hypomethylating Agents Significantly Improve Overall-and AML-Free Survival in Patients Classified As Very High Risk By IPSS-Rconference_abstract000349233801082